A preliminary validation of the brief international cognitive Assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS)

Conclusions This study demonstrates that BICAMS is an easy test to administer and should be used as a basic tool to identify patients with cognitive impairment who may benefit from further neuropsychological assessment. Cognitive impairment can put patients at risk of poor self-management of disease including poor mediation adherence, and negatively impact on employment. Once identified appropriate support and monitoring can be put in place. BICAMS may also be used to help guide treatment decisions and rehabilitation. Further studies will be needed to assess its reliability over time and ability to detect meaningful changes.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research